About BrainQ
BrainQ is a company based in Jerusalem (Israel) founded in 2011 by Yaron Segal. BrainQ has raised $48.8 million across 6 funding rounds from investors including OurCrowd, Norma Group and European Union. BrainQ offers products and services including Q Therapeutic System. BrainQ operates in a competitive market with competitors including Ceribell, Kernel, Perfuze, Openwater and MIVI Neuroscience, among others.
- Headquarter Jerusalem, Israel
- Founders Yaron Segal
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.8 M (USD)
in 6 rounds
-
Latest Funding Round
$56.62 K (USD), Grant
Dec 31, 2021
-
Investors
OurCrowd
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BrainQ
BrainQ offers a comprehensive portfolio of products and services, including Q Therapeutic System.
AI-powered wearable for accelerating stroke recovery at home.
People of BrainQ
Unlock access to complete
Funding Insights of BrainQ
BrainQ has successfully raised a total of $48.8M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $56.62 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BrainQ
BrainQ has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include OurCrowd, Norma Group and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Startups are funded through venture capital by Hanaco Ventures.
|
Locked | Locked | Locked | |
|
Peregrine is focused on healthcare innovation through strategic global investments.
|
Locked | Locked | Locked |
Investor details for BrainQ
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BrainQ
Investment portfolio details for BrainQ
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BrainQ
Detailed financials for BrainQ
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brainq Comparisons
Peer comparison for BrainQ
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BrainQ
BrainQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, Kernel, Perfuze, Openwater and MIVI Neuroscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
Multimodal brain measurement technology is developed for neuromedicine applications.
|
|
| Locked | Locked | Locked |
A medical device for acute ischemic stroke treatment is developed.
|
|
| Locked | Locked | Locked |
Provider of imaging technologies for medical diagnosis and treatments
|
|
| Locked | Locked | Locked |
Catheters and devices for acute ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
Stroke prevention device for atrial fibrillation patients is developed.
|
Detailed competitors of BrainQ
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brainq
Complete news archive for BrainQ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BrainQ
BrainQ was founded in 2011 and raised its 1st funding round 7 years after it was founded.
BrainQ is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Yotam Drechsler is the current CEO of BrainQ.
BrainQ is a funded company, having raised a total of $48.8M across 6 funding rounds to date.
BrainQ was founded in 2011 in Jerusalem, Israel, within the health technology sector. AI-powered electromagnetic stimulation technology is developed for stroke disability recovery. Tailored low-intensity and low-frequency fields are applied through an investigational device to support brain recovery processes. The device is intended for use in clinical and home settings across neurological rehabilitation operations. Patient independence is facilitated, and neurological functions are targeted for improvement.
BrainQ's top competitors include Ceribell, MicroTransponder and Perfuze.
BrainQ offers Q Therapeutic System.
BrainQ has 10 investors. Key investors include OurCrowd, Norma Group, European Union, EIC Fund, and Hanaco Ventures.